Expert Video - How do genetic testing results impact the treatment of my ovarian cancer?
The results of genetic testing is very important for ovarian cancer treatment. Gynecologic oncologist Dr. Scott Richard describes what PARP inhibitors are, how and when they are used to treat ovarian cancer, why they are effective and how they are used for ovarian cancer types specifically linked to genetic changes. Genetic testing can lead to more effective treatments and better outcomes for women with ovarian cancer.
This educational activity has been developed by the National Ovarian Cancer Coalition in collaboration with Mechanisms in Medicine Inc.
This activity is supported by educational grants from: Alkermes plc, AstraZeneca Pharmaceuticals LP, Clovis Oncology, Inc., Eisai Inc., Foundation Medicine, Inc., Genentech, a Member of the Roche Group, GSK, ImmunoGen, Inc., Merck & Co, Inc., Novartis, Novocure Inc., Pfizer, Inc.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.